Our previous study also showed that overexpression of ASPP2 reduced the level of triglyceride and total cholesterol in both the serum and liver using choline deficiency (MCD) diet-induced NAFLD mice model (29, 30). This evidence concerns the gene TP53BP2 and metabolic dysfunction-associated steatotic liver disease.